Lupin Pharmaceuticals Competitors and Similar CompaniesClear all

Lupin Pharmaceuticals's competitors and similar companies include Cipla, Alembic Pharmaceuticals and Re-Vana Therapeutics.

	Lupin Pharmaceuticals Lupin Pharmaceuticals is a company that specializes in the development and delivery of branded and generic medications.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	Re-Vana Therapeutics Re-Vana Therapeutics is a company that develops a biodegradable drug delivery platform.
Founding Date	Founding Date 2003	Founding Date 1935	Founding Date 2010	Founding Date 2015
Type	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech delivery drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech delivery drug development pharma
Locations	Locations HQ	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations Belfast, GB HQ
Employees	Employees 4,8111% increase	Employees 27,764	Employees 14,858	Employees 21
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ₹97.2b (FY, 2026)	Cost of goods ₹19.8b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₹184.4b (FY, 2026)	Gross profit ₹54.1b (FY, 2026)	Gross profit N/A
Net income	Net income N/A	Net income ₹38.7b (FY, 2026)	Net income ₹6.7b (FY, 2026)	Net income N/A
Operating ⚠
Products	Products N/A	Products 1.5 k (FY, 2024)	Products 145 (FY, 2024)	Products N/A